Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-09

Clinical Trial Update: Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex [Phase 4]

View source ↗

Summary

Phase 4 trial comparing neostigmine versus sugammadex for reversal of neuromuscular blockade. The study reports postoperative urinary retention outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine (neostigmine)
  • Sugammadex (sugammadex)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Urinary Retention Postoperative, Laparoscopic Cholecystectomy | Phase 4 | Status: COMPLETED | Results posted: 2024-10-09